CVS/pharmacy officially unveils new myWeekly Ad digital circular
WOONSOCKET, R.I. — Demonstrating CVS/pharmacy’s increased focus on personalization, the pharmacy retailer has officially unveiled its new myWeekly Ad, a first-of-its-kind digital circular experience powered by the CVS/pharmacy ExtraCare loyalty program.
As reported in the Oct. 14 issue of Drug Store News, the new myWeekly Ad is a digitized circular program that creates a personalized list of offers based on the actual items an ExtraCare member historically purchases. (For an in-depth examination of CVS Caremark’s personalization efforts across its entire retail operation, see the exclusive DSN special report.)
The new digitized circular, which soft-launched in mid-September, serves as the most recent example of how the retailer is personalizing the conversion of its best customers through ExtraCare.
The offers that shoppers will find within their personal digital version of the myWeekly Ad are specific to the SKU and store level, and the ads even instruct the customer where to find the items on the shelf at their local store.
CVS/pharmacy announced on Thursday that it is showcasing the new myWeekly Ad in a fun, playful way by kicking off a 360-degree marketing, advertising and social media campaign featuring three celebrities: Joan Rivers, Nick Cannon and George Hamilton. The "What’s Your Deal?" campaign highlights how CVS/pharmacy is a unifying shopping destination for all of these different characters — with something for everyone, which is at the heart of myWeekly Ad.
"Our ‘What’s Your Deal?’ campaign is a tongue-in-cheek way for us to unveil the savings revolution that is myWeekly Ad, where we’ve created a personalized circular that is as unique as each of our customers," stated Rob Price, chief marketing officer of CVS/pharmacy. "CVS/pharmacy’s myWeekly Ad is a convergence of technology and customer insights that revolutionizes savings. It acts as a matchmaker for our customers and their best deals."
myWeekly Ad – How It Works
The weekly ad is one of the longstanding and popular ways that CVS/pharmacy delivers value to customers. Shoppers can sign up for the new myWeekly Ad experience at cvs.com/myweeklyad by using an existing ExtraCare card number and CVS.com account information. New shoppers can also register online for an ExtraCare card and/or CVS.com account if they don’t already have one.
Once they sign up, users will have access to features including:
- "Your Deals:" While myWeekly Ad lets customers see all of the same deals featured in the traditional paper circular, the platform highlights up-front those products on sale each week that the individual users most frequently purchase.
- "Recommended Deals:" myWeekly Ad thinks for the customer — and suggests deals from the weekly circular that they might be interested in based on the categories and products they’ve purchased in the past.
- "ExtraCare Savings:" Shoppers can quickly scan all personalized savings and rewards currently available and choose to print or use "Send to Card" to digitally send select offers to their ExtraCare card before shopping.
- "myShopping List:" Customers can build their own digital shopping list featuring the deals they’d like to take advantage of each week, and it tells the customer exactly which aisle at their local store they’ll be able to find each of the products on their list. The shopping list is shareable and can be printed, emailed or viewed on a mobile phone.
- "myPurchase History:" myWeekly Ad also keeps a secure purchase history for users to reference. Customers can view the items they’ve purchased during the past 18 months and see if they are on sale, or add any of them to their current shopping list.
- Deal Details: Users can access information on all items that are part of an offer that week, eliminating any confusion about whether a specific product is part of the sale.
- Convenience On-The-Go: In addition to seeing their personalized offers on CVS.com, shoppers can also access myWeekly Ad via their mobile devices and tablets.
- Sneak Peek: Shoppers can see next week’s deals three days before the traditional circular is distributed on Sundays. Those enrolled can check back every week for new deals and can subscribe to email notifications to find out when new offers are available.
FDA approves Novo Nordisk’s Novoeight for hemophilia A
BAGSVÆRD, Denmark — The Food and Drug Administration has approved a new drug made by Novo Nordisk for treating hemophilia A, the Danish drug maker said.
Novo Nordisk announced the approval of Novoeight (turoctocog alfa), a recombinant coagulation factor VIII, for adults and children with hemophilia, a disease caused by factor VIII deficiency that results in uncontrollable bleeding.
"The approval of Novoeight marks an important step in offering a new alternative for people with hemophilia A and demonstrates our commitment to hemophilia," Novo Nordisk chief science officer and EVP Mads Krogsgaard Thomsen said.
The company plans to launch the drug in April 2015 and will launch it with a newly introduced prefilled injector called MixPro.
WomenHeart announces Science & Leadership Symposium graduates for 2013
WASHINGTON — Nearly two dozen women with heart disease will educate their communities about heart disease in women.
WomenHeart, a group focused on heart disease in women, said 23 women had graduated from the WomenHeart Science & Leadership Symposium at the Mayo Clinic in Rochester, Minn., to become WomenHeart Champions. The symposium is sponsored by the Medtronic Foundation, Boston Scientific, Edwards Lifesciences, Gilead, Astellas Pharma, AstraZeneca, Novartis, St. Jude Medical Foundation, Bristol-Myers Squibb and Genentech. The 2013 graduates join 628 graduates from previous years to become the "boots on the ground" to spread awareness about heart disease, the organization said; the symposium started in 2002.
"Heart disease can be a very emotionally and physically isolating condition for women," WomenHeart CEO Lisa Tate said. "WomenHeart Champions and the support networks that they build enable women to have the peer-to-peer support they need to make the lifestyle changes necessary to live a heart-healthy life."
Heart disease is the leading cause of death in women, and more women than men have died from heart disease every year since 1984, according to the group.